Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
acquiree, ARB, bargain, bloating, cannibalization, capsule, CDAD, cellulose, Chatou, Chlorothiazide, circumstance, coating, confidence, consulted, conventional, core, cultivate, database, deconsolidation, derecognizing, diabetic, DIACOL, difficile, domestic, dramatic, easier, Eisai, endpoint, erosion, famotidine, FAS, Freiberg, French, FSP, gastroesphageal, genericized, German, hoped, hurt, IBS, IIb, inclusion, instrument, Japanese, journal, lived, lost, Lotronex, mark, matrix, Mayoly, metoclopramide, noncash, noncontrolling, nonfinancial, nonrecurring, OGD, OS, ourC, overnight, Pathoen, polymer, recharacterized, recruitment, recurrent, redirect, remeasured, remeasurement, remission, replacement, revised, sampling, settlement, sirgo, slight, Spindler, strong, sublease, symptomatic, taxable, Tokyo, trust, uncured, unprofitable, unviable, USPTO, violated, Visiclear, waiver, workload, write, ZaCh, Zelnorm, Zeria
Removed:
achieve, agency, allocate, Alternatively, amortize, borne, borrowing, broadly, centralized, conform, controlled, coordinated, decentralized, determination, discontinue, dividend, England, EPS, Ernst, EU, eventual, executing, formally, important, investigate, Italian, mail, mandatory, marketplace, MCA, medicinal, notified, onset, participate, PLA, realization, recall, reclassified, regimen, retroactively, reviewing, roughly, security, speaking, submit, trend, valid, version, Young
Filing tables
Filing exhibits
- 10-K Annual report
- 10.61 Supply and Distribution Agreement
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification by the CEO
- 31.2 Certification by the CFO
- 32.1 Certification by the CEO Pursuant to 18 U.s.c. 1350
- 32.2 Certification by the CFO Pursuant to 18 U.s.c. 1350
Related press release
Salix Pharmaceuticals similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-110942) and Form S-8 (Nos. 333-126685, 333-126290, 333-116675, 333-96771, 333-63604, 333-61497, 333-135268 and 333-47586) of Salix Pharmaceuticals, Ltd. of our report dated March 13, 2008 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
March 13, 2008